# ZVS101e in Patients With Bietti's Crystalline Dystrophy

> **NCT07653971** · NA · NOT_YET_RECRUITING · sponsor: **Chigenovo Co., Ltd** · enrollment: 300 (estimated)

## Conditions studied

- Bietti's Crystalline Dystrophy
- Bietti Crystalline Corneoretinal Dystrophy

## Interventions

- **DRUG:** ZVS101e

## Key facts

- **NCT ID:** NCT07653971
- **Lead sponsor:** Chigenovo Co., Ltd
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2030-12-30
- **Final completion:** 2035-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07653971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07653971, "ZVS101e in Patients With Bietti's Crystalline Dystrophy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07653971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*